Access earnings results, analyst expectations, report, slides, earnings call, and transcript.

The earnings call revealed significant challenges, including declining revenue and gross profit, operational disruptions, and inventory management issues. The Q&A highlighted ongoing pressures on used vehicle gross profit and the need for a strategic reset. Although there is potential for improvement in the long term, the immediate outlook remains negative due to these persistent challenges and market underperformance.
The earnings report shows strong financial performance with significant revenue and gross profit growth, reduced net loss, and improved cash burn. The optimistic guidance for 2026, strong pipeline, and increased pricing for Model 2 suggest positive future prospects. Despite some management avoidance in addressing specific deal sizes, the overall sentiment is positive, supported by the transition to broader clinical utility and strategic market expansion.
The earnings call highlights strong financial performance with a 27% revenue increase and record gross margins, driven by new product launches. Although the company remains unprofitable, reduced cash burn and a robust pipeline suggest positive momentum. The Q&A reveals cautious optimism, with management focusing on near-term growth and international expansion challenges. The lack of 2026 guidance is a minor concern but is offset by positive indicators like increased sales and cash optimization, leading to a positive sentiment.
The earnings call summary and Q&A session reflect a positive outlook. Despite a slight net loss, the company shows strong financial discipline with reduced expenses and cash burn. Revenue guidance indicates significant growth, supported by new product launches and international expansion. The Q&A session highlights management's confidence in revenue drivers and market opportunities. While some responses lacked specificity, the overall sentiment is positive due to improved financial metrics, promising guidance, and strategic growth initiatives.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.